(Q37233513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Endothelin-1 (1-31): from chymase-dependent synthesis to cardiovascular pathologies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

P D'Orléans-Juste

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

G A Rae

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

G Bkaily

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

E Carrier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

E Simard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

12 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

51-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18675382%20AND%20SRC:MED&resulttype=core&format=json

Role of neutral endopeptidase in the metabolism of endothelin

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic alpha-keto heterocycles as novel inhibitors of human chymase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic difluoromethylene ketones as novel inhibitors of human chymase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

The extended cleavage specificity of the rodent beta-chymases rMCP-1 and mMCP-4 reveal major functional similarities to the human mast cell chymase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

The effect of big endothelin-1 in the proximal tubule of the rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Selective indole-based ECE inhibitors: synthesis and pharmacological evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A comparison of the efficacy of ketotifen (HC 20-511) with sodium cromoglycate (SCG) in skin test positive asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Role of endothelin-converting enzyme, chymase and neutral endopeptidase in the processing of big ET-1, ET-1(1-21) and ET-1(1-31) in the trachea of allergic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Selective and mixed endothelin receptor antagonism in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Intravascular big endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Human big-endothelin-1 and endothelin-1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Signaling by the angiotensin-converting enzyme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Reversible expansion of primate mast cell populations in vivo by stem cell factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Influence of endothelin-1(1-31) on smooth muscle tone and cholinergic nerve-mediated contraction in rat isolated trachea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Fertile dominant spotting in the house mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Evidence for a role of mast cells in the evolution to congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin generating pathway through endothelin1-31 in human cultured bronchial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Implications of species difference for clinical investigation: studies on the renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mast cells and endothelin-1: a life-saving biological liaison?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Effect of endothelin-1(1-31) on p38 mitogen-activated protein kinase in cultured human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Design and synthesis of a potent and selective endothelin-converting enzyme inhibitor, CGS 35066.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

An antiarrhythmic effect of a chymase inhibitor after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

ACE2 of the heart: From angiotensin I to angiotensin (1-7)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Novel 31-amino-acid-length endothelins cause constriction of vascular smooth muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Binding of a new bioactive 31-amino-acid endothelin-1 to an endothelin ET(B) or ET(B)-like receptor in porcine lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Effect of chymase on intraocular pressure in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mast cells: multipotent local effector cells in atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Rodent alpha-chymases are elastase-like proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Nedocromil sodium: a new drug for the management of bronchial asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Characterization of neutral endopeptidase 24.11 in dog glomeruli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Presence of furin mRNA in cultured bovine endothelial cells and possible involvement of furin in the processing of the endothelin precursor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mast cells as mediators and modulators of atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Genomic organisation of the mouse gene encoding endothelin-converting enzyme-1 (ECE-1) and mRNA expression of ECE-1 isoforms in murine tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Blood pressure responses of endothelin-1 1-31 within the rostral ventrolateral medulla through conversion to endothelin-1 1-21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Cardiovascular effects of centrally applied endothelin-1 1-31 and its relationship to endothelin-1 1-21 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Structure–Activity relationship of benzo[b]thiophene-2-sulfonamide derivatives as novel human chymase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mast cells promote homeostasis by limiting endothelin-1-induced toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-1(1-31) levels are increased in atherosclerotic lesions of the thoracic aorta of hypercholesterolemic hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-1[1-31], acting as an ETA-receptor selective agonist, stimulates proliferation of cultured rat zona glomerulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-A receptors mediate renal hemodynamic effects of exogenous Angiotensin II in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A novel 31-amino-acid-length endothelin, ET-1(1-31), can act as a biologically active peptide for vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Production of nitric oxide from endothelial cells by 31-amino-acid-length endothelin-1, a novel vasoconstrictive product by human chymase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mice lacking histidine decarboxylase exhibit abnormal mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Determination of the levels of novel 31-amino acid endothelins and endothelins in human lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Amino acid and peptide phosphonate derivatives as specific inhibitors of serine peptidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Disodium Cromoglycate, an Inhibitor of Mast Cell Degranulation and Histamine Release induced by Phospholipase A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-1 (1-31) induces a thiorphan-sensitive release of eicosanoids via ET(B) receptors in the guinea pig perfused lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Receptor and mechanism that mediate endothelin- and big endothelin-1-induced phosphoinositide hydrolysis in the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-1[1-31]: a novel autocrine-paracrine regulator of human adrenal cortex secretion and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Plaque rupture in humans and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A novel bioactive 31-amino acid ET-1 peptide stimulates eosinophil recruitment and increases the levels of eotaxin and IL-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Inhibition of dipeptidyl peptidase I in the human mast cell line HMC-1: blocked activation of tryptase, but not of the predominant chymotryptic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Cloning and functional expression of human endothelin-converting enzyme cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Identification and characterization of two isoforms of an endothelin-converting enzyme-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A role for cardiac mast cells in the pathogenesis of hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Attenuation of adhesion formation after cardiac surgery with a chymase inhibitor in a hamster model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Skin proteasomes (high-molecular-weight protease): purification, enzymologic properties, gross structure, and tissue distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Chymase processes big-endothelin-2 to endothelin-2-(1-31) that induces contractile responses in the isolated monkey trachea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Inhibition of chymase reduces vascular proliferation in dog grafted veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

An orally active chymase inhibitor, BCEAB, suppresses heart chymase activity in the hamster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Inhibition of human chymase by suramin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

SF2809 compounds, novel chymase inhibitors from Dactylosporangium sp. 1. Taxonomy, fermentation, isolation and biological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Altered processing of fibronectin in mice lacking heparin. a role for heparin-dependent mast cell chymase in fibronectin degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Regulation of extravascular coagulation and fibrinolysis by heparin-dependent mast cell chymase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Enzymatic pathways involved in the generation of endothelin-1(1-31) from exogenous big endothelin-1 in the rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mast cell chymase regulates dermal mast cell number in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Isoforms of endothelin-converting enzyme: why and where?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the beta-chymase, mouse mast cell protease-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Big ET-1 processing into vasoactive peptides in arteries and veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Serine proteases and cardiac function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Effect of endothelin-1(1-31) on intracellular free calcium in cultured human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Endothelin-1-(1-31), a novel vasoactive peptide, increases [Ca2+]i in human coronary artery smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Comparison of the effects of endothelin-1, -2 and -3 (1-31) on changes in [Ca2+]i in human coronary artery smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Effect of endothelin-1 (1-31) on human mesangial cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Preparative purification of the rat mast cell chymase. Characterization and Interaction with granule components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Mouse models for atherosclerosis and pharmaceutical modifiers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007

Modulation of histamine release from human colon mast cells by protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.06.007